EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Mitogen-Activated Protein Kinases: Therapeutic Signaling Catalysts in Viral Immune Evasion

Masood Alam Khan iD, Mohammad Hamza Khan, Khaled S Allemailem iD

Pathogens · 2026

DOI: 10.3390/pathogens15040384 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pathogens, 2026. Verfasst von Masood Alam Khan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Basic Health Sciences, College of Applied Medical Sciences, Qassim University, Buraydah 51452, Saudi Arabia. Hauptthemen laut MEDLINE: Immune Evasion, Mitogen-Activated Protein Kinases, Virus Diseases, MAP Kinase Signaling System. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The mitogen-activated protein kinase (MAPK) pathways, ERK, JNK, and p38, are key regulators of immune responses during viral infections. These signaling cascades control cytokine production, T cell activity, and antigen presentation. However, many viruses can hijack MAPK pathways to avoid immune detection, promote their replication, and establish chronic infection. In this review, we discuss how different viruses, including HSV-1, HBV, HCMV, and SARS-CoV-2, manipulate MAPK signaling to alter host cell functions. A particular focus is given to the CD1d–iNKT cell axis, which plays a critical role in early antiviral responses but is often disrupted through MAPK-dependent mechanisms. We explore how changes in MAPK signaling affect antigen-presenting cells, drive T cell exhaustion, and reprogram immune cell metabolism, factors that contribute to viral immune evasion. The review also examines therapeutic strategies aimed at targeting MAPKs to improve antiviral immunity. These include small-molecule inhibitors and immune modulators that may enhance antiviral responses while limiting side effects. We emphasize the importance of context, as MAPK-targeted therapies must be carefully timed and tailored to avoid suppressing protective immunity or triggering unwanted inflammation. Overall, this review highlights the therapeutic potential and challenges of targeting MAPK pathways in viral infections and encourages further research into selective, host-directed antiviral strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immune EvasionMitogen-Activated Protein KinasesVirus DiseasesMAP Kinase Signaling SystemHumansSARS-CoV-2Signal TransductionAntiviral AgentsAnimalsCOVID-19Host-Pathogen Interactions

Stichwörter der Autor:innen

MAP kinaseimmunityvaccinationviral proteinvirus pathogenesis

Substanzen

Mitogen-Activated Protein KinasesAntiviral Agents

Autor:innen und Institutionen

  • Department of Basic Health Sciences, College of Applied Medical Sciences, Qassim University, Buraydah 51452, Saudi Arabia.
  • Jawaharlal Nehru Medical College and Hospital, Aligarh Muslim University, Aligarh 202002, India.
  • Department of Medical Laboratories, College of Applied Medical Sciences, Qassim University, Buraydah 51452, Saudi Arabia.

ORCID-Profile: Masood Alam Khan, Khaled S Allemailem

Zitieren

APA

Khan, M. A., Khan, M. H., & Allemailem, K. S. (2026). Mitogen-Activated Protein Kinases: Therapeutic Signaling Catalysts in Viral Immune Evasion. Pathogens. https://doi.org/10.3390/pathogens15040384

Vancouver

Khan MA, Khan MH, Allemailem KS. Mitogen-Activated Protein Kinases: Therapeutic Signaling Catalysts in Viral Immune Evasion. Pathogens. 2026. doi:10.3390/pathogens15040384

BibTeX
@article{Khan2026,
  author = {Khan, Masood Alam and Khan, Mohammad Hamza and Allemailem, Khaled S},
  title = {Mitogen-Activated Protein Kinases: Therapeutic Signaling Catalysts in Viral Immune Evasion},
  journal = {Pathogens},
  year = {2026},
  doi = {10.3390/pathogens15040384}
}
Kostenlos starten →